Production (Stage)
Cadrenal Therapeutics, Inc.
CVKD
$13.69
-$0.014-0.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -164.78% | -27.45% | 40.71% | 51.36% | 60.66% |
| Total Depreciation and Amortization | 183.33% | -5.00% | -8.70% | 4.55% | 50.00% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Other Non-Cash Items | 207.58% | -69.60% | -91.87% | -93.68% | -93.83% |
| Change in Net Operating Assets | 180.51% | 1,198.20% | 182.64% | 2,131.03% | 692.95% |
| Cash from Operations | -157.21% | -108.41% | -93.51% | -54.94% | -47.35% |
| Capital Expenditure | -196.97% | -96.97% | 100.00% | 100.00% | -32.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -196.97% | -96.97% | 100.00% | 100.00% | -32.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | 10.62% | -57.72% | -87.44% | 14.99% | 14.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 68.58% | -24.56% | -87.63% | 4.69% | 3.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.68% | -80.70% | -152.67% | -43.04% | -28.89% |